NS5A inhibitors

BMS 215 Pill - green five-sided

Generic Name: daclatasvir

Pill with imprint BMS 215 is Green, Five-sided and has been identified as Daklinza 60 mg. It is supplied by Bristol-Myers Squibb Company.

Daklinza is used in the treatment of Hepatitis C and belongs to the drug class NS5A inhibitors. Daklinza 60 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Daklinza (Daclatasvir [ dak-lat-as-vir ])-BMS 215-60 mg-Green-Five-sided
Daklinza (Daclatasvir [ dak-lat-as-vir ])-BMS 215-60 mg-Green-Five-sided

Daklinza
Generic Name: daclatasvir [ dak-lat-as-vir ]
Imprint: BMS 215
Strength: 60 mg
Color: Green
Size: N/A
Shape: Five-sided
Availability: Prescription only
Drug Class: NS5A inhibitors
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00003-0215 (Discontinued)
Inactive Ingredients: Lactose anhydrous, Microcrystalline cellulose, Croscarmellose sodium, Silicon dioxide, Magnesium stearate, Titanium dioxide, Polyethylene glycol 400, FD&C Blue No. 2, Indigotindisulfonate sodium, Aluminum oxide, Ferric oxide yellow,
Latest News
Related Drugs